HK1153644A1 - Adiponectin for treating pulmonary disease - Google Patents

Adiponectin for treating pulmonary disease

Info

Publication number
HK1153644A1
HK1153644A1 HK11105943.4A HK11105943A HK1153644A1 HK 1153644 A1 HK1153644 A1 HK 1153644A1 HK 11105943 A HK11105943 A HK 11105943A HK 1153644 A1 HK1153644 A1 HK 1153644A1
Authority
HK
Hong Kong
Prior art keywords
pulmonary disease
adiponectin
agent
treating pulmonary
present
Prior art date
Application number
HK11105943.4A
Other languages
English (en)
Inventor
Kounori Kotosai
Kazuyoshi Kirima
Keiko Karasutani
Yasukazu Ohmoto
Yoichi Yabuuchi
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of HK1153644A1 publication Critical patent/HK1153644A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2264—Obesity-gene products, e.g. leptin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/785—Alveolar surfactant peptides; Pulmonary surfactant peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Genetics & Genomics (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
HK11105943.4A 2008-08-27 2011-06-13 Adiponectin for treating pulmonary disease HK1153644A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2008217721 2008-08-27
PCT/JP2009/065380 WO2010024460A1 (en) 2008-08-27 2009-08-27 Adiponectin for treating pulmonary disease

Publications (1)

Publication Number Publication Date
HK1153644A1 true HK1153644A1 (en) 2012-04-05

Family

ID=41478949

Family Applications (1)

Application Number Title Priority Date Filing Date
HK11105943.4A HK1153644A1 (en) 2008-08-27 2011-06-13 Adiponectin for treating pulmonary disease

Country Status (26)

Country Link
US (2) US20110218146A1 (pt)
EP (2) EP2323686B8 (pt)
JP (2) JP5618993B2 (pt)
KR (1) KR20110056394A (pt)
CN (1) CN102292100A (pt)
AR (1) AR073133A1 (pt)
AU (1) AU2009284876A1 (pt)
BR (1) BRPI0917149A2 (pt)
CA (1) CA2735263A1 (pt)
CO (1) CO6321161A2 (pt)
CY (1) CY1114125T1 (pt)
DK (1) DK2323686T3 (pt)
ES (1) ES2421151T3 (pt)
HK (1) HK1153644A1 (pt)
HR (1) HRP20130695T1 (pt)
IL (2) IL211346A0 (pt)
MX (1) MX2011002158A (pt)
MY (1) MY152044A (pt)
PL (1) PL2323686T3 (pt)
PT (1) PT2323686E (pt)
RU (2) RU2490023C2 (pt)
SI (1) SI2323686T1 (pt)
TW (2) TW201500053A (pt)
UA (1) UA100296C2 (pt)
WO (1) WO2010024460A1 (pt)
ZA (1) ZA201101366B (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE45394E1 (en) 2008-10-20 2015-03-03 X6D Limited 3D glasses
US8542326B2 (en) 2008-11-17 2013-09-24 X6D Limited 3D shutter glasses for use with LCD displays
USD692941S1 (en) 2009-11-16 2013-11-05 X6D Limited 3D glasses
USD711959S1 (en) 2012-08-10 2014-08-26 X6D Limited Glasses for amblyopia treatment
US11111284B2 (en) 2014-08-21 2021-09-07 The General Hospital Corporation Tumor necrosis factor superfamily and TNF-like ligand muteins and methods of preparing
CN110724186A (zh) * 2019-10-29 2020-01-24 四川农业大学 西伯利亚鲟球形脂联素蛋白基因原核表达的方法及应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5869330A (en) 1995-06-05 1999-02-09 Whitehead Institute For Biomedical Research DNA encoding a novel serum protein produced exclusively in adipocytes
WO1999002157A1 (fr) 1997-07-09 1999-01-21 Toray Industries, Inc. Antitussifs
JP3538711B2 (ja) * 1997-10-29 2004-06-14 大塚製薬株式会社 平滑筋増殖抑制組成物、動脈硬化症診断方法及びそのキット
JP3018186B1 (ja) 1999-03-09 2000-03-13 大阪大学長 抗炎症剤、単球系細胞の増殖抑制剤
CA2422805C (en) * 2000-10-02 2010-09-14 F. Hoffmann-La Roche Ag Retinoids for the treatment of emphysema
NZ534699A (en) * 2002-01-18 2008-12-24 Protemix Corp Ltd Glycoisoforms of adiponectin and uses thereof
AU2003234845A1 (en) 2002-05-24 2003-12-12 Japan Science And Technology Agency Preventive/remedy for arteriosclerosis
JP4212304B2 (ja) 2002-06-14 2009-01-21 独立行政法人科学技術振興機構 Ａｍｐ活性化プロテインキナーゼ活性化剤
JP2004345968A (ja) * 2003-05-20 2004-12-09 Takashi Kadowaki アディポネクチンの新規用途
EP1830873A4 (en) * 2004-12-10 2008-04-02 Protemix Corp Ltd GLYPONECTIN (ADIPONECTIN GLYCOSYLE) FOR THE TREATMENT OF DISEASES AND CONDITIONS
CN101415461A (zh) * 2006-01-09 2009-04-22 儿童医院医疗中心 用于治疗各种疾病的脂连蛋白

Also Published As

Publication number Publication date
RU2011111432A (ru) 2012-10-10
RU2013123003A (ru) 2014-11-27
IL234693A0 (en) 2014-11-30
CA2735263A1 (en) 2010-03-04
US20130345133A1 (en) 2013-12-26
ZA201101366B (en) 2012-05-30
CN102292100A (zh) 2011-12-21
PT2323686E (pt) 2013-07-11
TW201500053A (zh) 2015-01-01
CO6321161A2 (es) 2011-09-20
HRP20130695T1 (hr) 2013-09-30
UA100296C2 (uk) 2012-12-10
WO2010024460A1 (en) 2010-03-04
RU2490023C2 (ru) 2013-08-20
JP5618993B2 (ja) 2014-11-05
DK2323686T3 (da) 2013-06-03
JP2012501297A (ja) 2012-01-19
JP5808470B2 (ja) 2015-11-10
EP2323686B8 (en) 2013-07-03
EP2614831A1 (en) 2013-07-17
CY1114125T1 (el) 2016-07-27
US20110218146A1 (en) 2011-09-08
JP2015038090A (ja) 2015-02-26
PL2323686T3 (pl) 2013-09-30
KR20110056394A (ko) 2011-05-27
EP2323686B1 (en) 2013-05-15
AR073133A1 (es) 2010-10-13
BRPI0917149A2 (pt) 2015-12-01
MY152044A (en) 2014-08-15
AU2009284876A1 (en) 2010-03-04
SI2323686T1 (sl) 2013-07-31
MX2011002158A (es) 2011-03-29
ES2421151T3 (es) 2013-08-29
EP2323686A1 (en) 2011-05-25
IL211346A0 (en) 2011-05-31
TW201014598A (en) 2010-04-16

Similar Documents

Publication Publication Date Title
HRP20130695T1 (hr) Adiponektin za lijeäśenje pluä†ne bolesti
WO2010021693A3 (en) Mif modulators
WO2011140202A3 (en) Mif modulators
WO2012024620A3 (en) Autotaxin inhibitors and uses thereof
HK1216615A1 (zh) 治療或預防大腸桿菌導致的經口感染的組合物和方法
WO2014144100A3 (en) Sgc stimulators
GEP20146082B (en) Compositions and methods of wnt signaling modulators
WO2015070224A3 (en) Combination therapy including an mdm2 inhibitor and one or more additional pharmaceutically active agents for the treatment of cancers
IL195030A (en) IV dpp inhibitor assemblies
HK1133787A1 (en) Bicycloheteroaryl compounds as p2x7 modulators and uses thereof
TN2010000122A1 (en) Compounds and compositions as modulators of gpr119 activity
WO2015077503A8 (en) Autotaxin inhibitor compounds
AR063628A1 (es) Compuestos de piridinona utiles para el tratamiento de cancer
WO2006102610A3 (en) Bicycloheteroaryl compounds as p2x7 modulators and uses thereof
MX2009000285A (es) Piperidinas sustituidas que incrementan la actividad de p53 y usos de las mismas.
EA200900155A1 (ru) Модуляторы фармакокинетических свойств лекарственных средств
IL193074A0 (en) Stable pharmaceutical formulations of montelukast sodium
WO2009024611A3 (en) 4-benzylaminoquinolines, pharmaceutical compositions containing them and their use
WO2007109172A3 (en) Bicycloheteroaryl compounds as p2x7 modulators and uses thereof
UA98839C2 (en) N,n-disubstituted aminoalkylbiphenyl antagonists of prostaglandin d2 receptors
WO2007109154A3 (en) Bicycloheteroaryl compounds as p2x7 modulators and uses thereof
WO2007109160A3 (en) Bicycloheteroaryl compounds as p2x7 modulators and uses thereof
MX368903B (es) Compuestos terapéuticos y sus usos en el tratamiento de enfermedades proliferativas.
MX2009004862A (es) Estabilizacion de vacunas por liofilizacion.
WO2007028022A3 (en) Novel compounds as p2x7 modulators and uses thereof

Legal Events

Date Code Title Description
AM Amended specification (according sect 146 of patent law)

Free format text: CORRECTION OF THE ENGLISH NAME OF APPLICANT FROM OTSUKA PHARMA CO LTD TO OTSUKA PHARMACEUTICAL CO., LTD

Effective date: 20130226

PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20170827